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Vitamin D status and blood pressure in
children and adolescents: a systematic
review of observational studies
Myriam Abboud1* , Fatme Al Anouti1, Dimitrios Papandreou1, Rana Rizk2, Nadine Mahboub3,4 and Suzan Haidar3

Abstract
Background: Childhood hypertension is a growing public health problem. Simultaneously, hypovitaminosis D is
widespread in this population and could be associated with hypertension. This study systematically reviewed the
literature on the relationship between vitamin D status and blood pressure (BP) in children and adolescents.
Methods: Following the PRISMA guidelines, PUBMED, MEDLINE, CINAHL, EMBASE, Cochrane Library, and
ClinicalTrials.gov and the gray literature without language or time restrictions were searched. We included
observational studies, assessed their risk of bias, and extracted data on population characteristics, vitamin D status
and BP measurements, and the association between the two variables. A narrative analysis of the studies was
performed.
Results: In total, 85 studies were included. Prospective cohort studies showed no association between vitamin D
and BP, and generally, they were flawed. Also, the majority of non-prospective cohort studies (cross-sectional,
retrospective, case-control) did not report an association between vitamin D and BP. They were mostly flawed
regarding BP measurement and adjusting to potential confounders.
Conclusion: The results on the relationship between vitamin D status and BP in children and adolescents varied
between the studies, and mainly pointed towards lack of association.
Keywords: Vitamin D, Blood pressure, Children, Adolescents, Systematic review

Background
Childhood hypertension is a serious public health burden, of considerable consequences [1]. In 2018, the global prevalence of childhood hypertension was estimated
to be 4%, representing a substantial rise during the past
two decades [2]. Between 2000 and 2015, the prevalence
of hypertension showed a substantial increase among
children aged 6 to 19 years [2]. This trend of increasing
prevalence is expected to persist in the future, putting
children at danger and further burdening health care
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systems [2]. Primary hypertension in childhood is commonly associated with cardiovascular risk factors, obesity, left ventricular hypertrophy, retinal vascular, and
cognitive changes [3] and is associated with essential
hypertension in adulthood [4, 5]. The increasing prevalence of hypertension is multifaceted, and its main driver
is a higher body mass index (BMI) [2].
Simultaneously, hypovitaminosis D or low serum levels
of hydroxyvitamin D (25(OH)D), is widespread in children and adolescents worldwide, even in countries which
have plentiful sunlight all-year round [6–8]. The most
common determinants of deficiency include limited exposure to sunlight, low dietary vitamin D intake, and
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sequestration in fat tissue especially among obese children and adolescents [9–12].
There is a general consensus that sufficient vitamin D
levels during childhood promote skeletal growth and development. Yet, attention is being increasingly given to
the extraskeletal benefits attained by having adequate
vitamin D status [13]. Emerging evidence suggests that
low serum vitamin D level is associated with poor health
outcomes in the pediatric population, specifically
obesity-related chronic health conditions, most notably
hypertension [14, 15]. Obese youth with lower vitamin D
levels have showed increased odds for hypertension, and
this association remained significant even after adjusting
for either BMI or total fat mass [16]. Moreover, an inverse association between 25(OH)D and systolic blood
pressure (SBP) has been noted [17]. Several biologically
plausible hypotheses support the beneficial effect of adequate vitamin D status on blood pressure (BP), including the role of vitamin D in improving endothelial
function, decreasing proinflammatory cytokine levels,
and regulating the renin-angiotension-aldosterone system [18–23].
To date, human interventional studies have failed to
produce conclusive evidence pertaining to vitamin D as
a potential antihypertensive supplement. A recent systematic review conducted by Abboud [24] revealed no
benefit of vitamin D supplementation on decreasing SBP
or diastolic blood pressure (DBP). This could be explained by the fact that other factors, rather than simply
dietary intake, determine vitamin D status and its health
implications. Vitamin D status can vary quite markedly
in groups of people with apparently similar input level
and is affected by calcium intake, some therapeutic
agents, adiposity levels, and exercise [25]. Attaining adequate vitamin D status for preventing hypertension
could thus be of public health relevance. Therefore, this
study aims to systematically review the literature to decipher the relationship between vitamin D status and BP
in children and adolescents.

Methods
Review design

This is a systematic review conducted according to the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement [26] (see Additional
file 1) and following a predefined protocol that was registered with the International Prospective Register of
Systematic Reviews (PROSPERO) (CRD42020167550).
Ethical approval was not required for this purpose.
The databases PUBMED, MEDLINE (Ovid), CINAHL
(EBSCO), EMBASE (Ovid), the Cochrane Library, and
http://www.ClinicalTrials.gov, were searched as well as
the references of included articles, and previous reviews
of vitamin D and BP in children and adolescents
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identified by the search. The search included observational studies reporting on the association between vitamin D status and BP (systolic, diastolic, or mean arterial
pressure (MAP)) in children and adolescents. There
were no language or time restrictions to eligible reports.
Search strategy

Our search strategy included three key concepts: (1)
vitamin D, (2) blood pressure, and (3) children and adolescents, and for each concept, we mapped Medical Subject Headings (MeSH) and keywords. The search
included terms such as vitamin D, cholecalciferol, ergocalciferol, or calcidol, combined with BP or hypertension, and pediatric, child, adolescent, youth, or teenage.
We did not apply time restrictions to the search, i.e., the
databases were searched from their inception date
through January 17, 2020. In addition, we conducted a
search update on June 09, 2020. A medical information
specialist validated the electronic search strategy (see
Additional file 2). The references retrieved from scientific databases were managed using EndNote software,
version X6.
Study selection

The selection included prospective cohort, crosssectional, case-control, or retrospective studies including
children and adolescents as defined by the studies (e.g.,
aged less than 18 years). Observational studies evaluating
the relationship between vitamin D status (e.g.,
25(OH)D blood level) and BP were also considered. The
outcomes of interest included the difference in measured
BP readings, or the odds of increased BP, or the differences in the prevalence of hypertension between participants with suboptimal vitamin D status, e.g., deficiency,
and those with adequate levels of vitamin D. The outcomes of interest also included the correlation between
vitamin D levels and BP levels, and the difference in vitamin D levels across groups of BP (e.g., normotensive vs.
hypertensive). Mixed studies (including children, adolescents, and adults) were included if there was a subgroup
analysis for children and/or adolescents only.
This review excluded studies evaluating the effect of
vitamin D supplementation on BP reduction as well as
studies investigating the association between hypervitaminosis D and BP. Also excluded were studies conducted on adult participants as defined by the studies
(e.g., aged 18 years and above), pregnant women, neonates (aged 0 to 30 days), and infants (aged 1 month to
2 years), as classified by the World Health Organization,
participants with diseases affecting vitamin D metabolism (e.g., chronic kidney disease, dialysis, liver disease,
parathyroid abnormality, and vitamin D-dependent rickets types 1 and 2), participants taking medications
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known to interfere with vitamin D metabolism (e.g.,
phenytoin, phenobarbital, carbamazepine, and rifampin).
Screening of titles and/or abstracts retrieved by the
search was done in duplicate on EndNote software, version X6, and eligible studies were identified. Two pairs
of authors (M.A. and R.R.; N.M. and S.H.) then retrieved
the full texts of these studies and assessed them for eligibility in duplicate. Disagreements were solved through
discussion. A calibration exercise was conducted before
study selection to ensure the validity of the process.

Data extraction

Data from eligible studies were extracted in duplicate by
two pairs of authors (M.A. and R.R.; N.M. and S.H.) on
Microsoft Excel 2016, following a data extraction standard form. A calibration exercise was first conducted. Disagreements were resolved through discussion The
following details were retained: characteristics of the
study, details of the population included, the studied exposures and outcomes, and the main findings and adjustments to the analyses, as applicable. Serum 25(OH)D
measures were converted to nanomoles per liter whenever it was reported as nanograms per milliliter, by
multiplying by a factor of 2.496.

Fig. 1 PRISMA diagram of study selection
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Risk of bias assessment

After an initial calibration exercise, two pairs of authors
(M.A. and R.R.; N.M. and S.H.) collaboratively assessed
in duplicate the risk of bias of included studies, solving
disagreements between them through discussion. We
used a modified version of the Cochrane Risk of Bias
tool [27] that is designed to assess to risk of bias of observational studies. Each potential source of bias was
graded as low, high, or unclear risk. The criteria for
judging a high risk of bias included failure to develop
and apply appropriate eligibility criteria; flawed measurement of both exposure and outcome; failure to adequately control confounding; and incomplete follow-up
(only for prospective cohort studies).

Data synthesis

Separate narrative analyses of the findings of prospective
cohort and non-prospective cohort studies were performed. Furthermore, we provided separate analyses for
non-prospective studies based on the level of adjustment
for confounding factors. We opted for this method of
analysis because failure to take into account confounding factors decreases the quality of the evidence generated by the study [27].
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Results
Search results

The details of the search process are detailed in Fig. 1. A
total of 85 studies [14–16, 28–108] were included in the
systematic review.
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three studies, only Wang et al. [99] studied vitamin D
levels across SBP status groups (< 75th percentile vs. ≥
75th percentile) during childhood and reported no association between the two variables (p = 0.05).
Assessment of risk of bias

Prospective cohort studies
Characteristics of the studies

We identified three prospective cohort studies [60, 99,
102], which characteristics are detailed in Table 1. These
studies were published between 2014 [102] and 2019
[99], and were conducted in Australia [60], United States
of America (USA) [99], and England [102].
Results of the studies

The findings from the prospective cohort studies are
also presented in Table 1. Two [60, 102] out of three
studies showed no association between vitamin D and
BP (SBP and DBP), whereas one [99] showed an inverse
association between low vitamin D status during early
childhood and SBP a decade later, which was rendered
not significant after adjustment for weight status.
In details, Ke et al. [60] examined 25(OH)D concentrations in an Australian cohort of 8-year-olds (n = 249)
followed up at age 15 (n = 162) and explored associations between 25(OH)D with cardiovascular disease
(CVD) risk factors, including BP, in these populations.
On the cross-sectional analyses of 8- and 15-year-olds,
SBP and DBP were not found to be significantly associated with 25(OH)D concentrations. Of interest, prospectively there was no association between 25(OH)D at
age 8 and SBP nor DBP at age 15, both in boys and in
girls. Similarly, Williams et al. [102] compared prospective associations of two analogs of childhood 25(OH)D
(25(OH)D2 and 25(OH)D3) at ages 7–12 years with SBP
and DBP measured in adolescence. The analyses were
conducted on 2470 participants of the Avon Longitudinal Study of Parents and Children (ALSPAC)—a prospective birth cohort that recruited pregnant women in
the former county of Avon, South West England. The
results of this study showed that there were no associations between vitamin D measured during childhood
with SBP and DBP at mean age of 15.5 years. Finally,
among 775 children from the Children’s Health Study
(CHS)—a prospective birth cohort study recruiting children from the original Boston Birth Cohort at Boston
Medical Center, Wang et al. [99] investigated whether
vitamin D status in early life can affect SBP a decade
later and reported not association between the two variables at ages 3 to 5 years. Further, Wang et al. [99] reported higher odds of elevated SBP at age 6 to 18 years
among children with lower vitamin D during early childhood; however, this result was rendered not significant
when adjusted for current weight status. Among the

The assessment of risk of bias of prospective cohort
studies is presented in Fig. 2. Developing and/or applying appropriate eligibility criteria were appropriate in the
three studies. The assessment of vitamin D was adequate
in Ke et al. [60] and Wang et al. [99], yet not reported in
Williams et al. [102]. The assessment of BP was adequate in Ke et al. [60], yet, it was not reported in Williams et al. [102]. In Wang et al. [99], the number of BP
measurements was not reported; thus, the risk of bias
was unclear. The three studies extensively adjusted to
potential confounders regarding the association between
vitamin D and BP. Finally, there was no suspicion of differential loss to follow-up in Ke et al. [60] and Wang
et al. [99]; however, in Williams et al. [102], there were
numerous significant differences in the characteristics of
included and excluded participants because of missing
data on one or more variable, which might imply a high
risk of bias.
Non- prospective cohort studies (cross-sectional,
retrospective and case-control studies)
Characteristics of the studies

Table 2 details the characteristics of non-prospective cohort studies. The included studies were published between 2007 [95] and 2020 [47, 57, 82, 92, 105]. The
majority of the studies were conducted in the Americas
(USA, n = 23 [15, 33, 34, 36, 37, 40, 43, 65, 66, 69, 75,
79–81, 84, 86, 91, 92, 95, 100, 103, 107]; Latin America,
n = 9 [53–56, 74, 83, 96–98]; Canada, n = 1 [71]),
followed by Asia (n = 33) [14, 28–32, 35, 38, 39, 44, 48–
50, 57–59, 61–64, 67, 68, 70, 72, 73, 76–78, 88, 90, 105,
106, 109], Europe (n = 14) [42, 45–47, 51, 82, 85, 87, 89,
93, 94, 101, 104, 108], Australia (n = 1) [16], and Africa
(n = 1) [52]. The majority of the studies were crosssectional (n = 67) [14, 15, 28, 29, 31–38, 40–48, 50–59,
61, 62, 64, 65, 68, 69, 72–78, 80, 81, 83–93, 96–98, 100,
104–109], and there were seven retrospective studies
[16, 39, 49, 66, 71, 95, 103], one case-control study [70].
We also identified four articles [30, 63, 82, 94] which included a cross-sectional baseline assessment from human interventional studies, and two from prospective
cohort studies [67, 101] and one article [79] included
data from both prospective cohort (baseline assessment)
and cross-sectional studies. The sample size ranged from
22 [35] to 9757 [65] participants; the age of participants
ranged from 1 to 21 years [65]. Five studies included females only [36, 37, 58, 63, 90], while one study [53] consisted of males only. Twelve studies [15, 61, 64, 65, 68,

Abboud et al. Systematic Reviews

(2021) 10:60

Page 5 of 30

Table 1 Characteristics and results of prospective cohort studies
First
author,
yearcountry

Study population

Outcomes evaluated and Adjusted variables for statistical Key findings
evaluation method
analysis

Ke, 2018Australia
[60]

249 healthy Australian children
recruited at age 8, 162 followed
up at age 15
Mean BMI (SD) in kg/m2 at 8
years: 16.7(2.3)
Mean BMI (SD) in kg/m2 at 15
years: 22.2 (3.8)
% Male at age 8: 47.4%; at age 15:
54.3%
Age in years: Range: 5.9–8.5;
Mean (SD) at 8 years: 7.8 (0.6); at
15 years: 14.9 (0.2)

Serum 25(OH)D:
Radioimmunoassay
SBP and DBP: average of 3
readings by an automated
BP monitor after a 5 min
rest

Age; Date of blood draw; Sum of
skinfolds; Socioeconomic status;
Body fat

● At 8 years old: No association
between 25(OH)D and log SBP
(standardized β: 0.004; NS); and
log DBP (standardized β: − 0.049;
NS)
● At 15 years old: No association
between 25(OH)D and log SBP
(standardized β: − 0.06; NS);
Significant inverse association
between 25(OH)D and log DBP
(standardized β: − 0.19; p = 0.015)
● No association between
25(OH)D at age 8 and BP at age
15 in boys [SBP (standardized β: −
0.18; p = 0.2); DBP (standardized β:
-0.06; NS)] and girls [SBP
(standardized β: 0.11; NS); DBP
(standardized β: − 0.1; NS)]

Wang,
2019Boson,
USA [99]

775 black and other children from
the original Boston Birth Cohort,
enrolled from 2005 to 2012 and
followed prospectively up to age
18 years at a medical center
Mean BMI (SD) in kg/m2: NR
% Male: 49.8%
Age in years: Median (IQR) for last
BP measurement: 10.7 (8.7–12.3)

Plasma 25(OH)D2 and
25(OH)D3: HPLC-tandem
mass spectrometry assay
SBP: validated automatic
sphygmomanometer, on
the right arm, in a sitting
position with an
appropriately sized cuff
Elevated SBP: BP ≥ 75th p
for age, gender, and
height

Maternal age; Race; Education;
Smoking; Parity; Hypertensive
disorder; Diabetes mellitus; Prepregnancy obesity; Preterm birth;
Birthweight; Season at birth and
season at measurement; Breastfeeding; Child’s age at BP measurement; Sex; Current overweight
or obesity
None for vitamin D across SBP
groups

● No association between low
vitamin D status during early
childhood and SBP at ages 3 to 5
years. Higher odds of elevated SBP
at 6 to 18 years of age with low
vitamin D status in early
childhood, rendered not
significant when adjusted for
current weight status: OR for low
vitamin D status during early
childhood and SBP at 3–5 years
[OR 0.96 (95%CI 0.62–1.49); p =
0.859] and 6–18 years [OR 1.56
(95%CI 1.00–2.44); p = 0.051]
● No difference in plasma
25(OH)D in childhood, according
to Child Systolic BP p: 83.12 (28.2)
nmol/L for < 75 p vs. 78.87 (24.71)
nmol/L for ≥ 75 p; p = 0.050

Williams,
2014Avon,
Southwest
England
[102]

2470 participants of the Avon
25(OH)D2 and 25(OH)D3:
Longitudinal Study of Parents and NR
Children at 15-year of follow-up
SBP and DBP: NR
Mean (SD) BMI: 21.5 (3.7)
% Male: 49.5%
Age in years: Range: 7–12; Mean:
15.4; Mean (SD) at 25(OH)D
sampling: 10.0 (0.9)

Age; Gender; Socioeconomic
status; Childhood BMI; Follow-up
BMI; Season-adjusted 25(OH)D3;
PTH; Circulating calcium and
phosphate

NS association between vitamin D
measured during childhood (at
mean age 7.4, 9.8, or 11.7 years)
and BP at mean age 15.5 years
● Mean difference per doubling of
25(OH)D2
SBP: Mean difference: − 0.12 (95%
CI − 0.61, 0.39); p = 0.65
DBP: Mean difference: − 0.10 (95%
CI − 0.59, 0.37); p = 0.68
● Mean difference per doubling of
25(OH)D3
SBP: Mean difference: 0.47 (95% CI
− 0.45, 1.35); p = 0.29
DBP: Mean difference: − 0.06 (95%
CI − 0.87, 0.75); p = 0.88
● Mean difference between
25(OH)D 50–72 nmol/L vs.
25(OH)D ≥ 72 nmol/L
SBP: Mean difference: 0.58 (95% CI
− 0.41, 1.57)
DBP: Mean difference: 0.65 (95% CI
− 0.18, 1.48)
● Mean difference between
25(OH)D < 50 nmol/L vs. 25(OH)D
≥ 72 nmol/L
SBP: Mean difference: − 0.60 (95%

Abboud et al. Systematic Reviews

(2021) 10:60

Page 6 of 30

Table 1 Characteristics and results of prospective cohort studies (Continued)
First
author,
yearcountry

Study population

Outcomes evaluated and Adjusted variables for statistical Key findings
evaluation method
analysis

CI − 1.69, 0.49)
DBP: Mean difference: 0.17 (95% CI
− 0.75, 1.08)
BMI body mass index, SD standard deviation, 25(OH)D 25-hydroxyvitamin D, SBP systolic blood pressure, DBP diastolic blood pressure, BP blood pressure, Β beta,
NS not significant, USA United States of America, NR not reported, IQR interquartile range, 25(OH)D2 25-hydroxyvitamin D2, 25(OH)D3 25-hydroxyvitamin D3, HPLC
high-performance liquid chromatography, p Percentile, OR odds ratio, CI confidence interval

75, 77–79, 91, 100, 105] included nationally representative samples. Twenty studies included obese/overweight
participants [16, 33, 34, 37, 38, 41, 47, 49, 62, 69, 71, 84,
88, 89, 95, 96, 98, 103, 104, 107]; one study [43] included
children with multiple, modifiable atherosclerosispromoting risk factors; one [79] was conducted on youth
with type 1 diabetes. Only one study [93] recruited children and adolescents with primary hypertension, and
only one [35] included healthy children with vitamin D
deficiency.

Fig. 2 Risk of bias of prospective cohort studies

Results of the studies

The findings of non-prospective cohort studies are also
available in Table 2 (see Additional file 3 for the detailed
numerical results of the studies). Among the 36 studies
[27–34, 38–41, 43, 44, 47, 49, 51, 52, 59, 63, 66, 69, 71–
73, 77, 81, 88, 89, 92, 93, 95, 96, 98, 104, 108, 109] that
did not adjust for potential confounders, ten [28, 29, 31,
47, 73, 89, 92, 95, 98, 109] found a significant inverse association between vitamin D and SBP (of which three
[29, 31, 109] in boys only), while the majority (n = 25)
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Table 2 Characteristics and results of non-prospective cohort studies
First author,
year- country

Study population

Outcomes evaluated and
evaluation method

Adjusted variables for
statistical analysis

Key findings

Cross-sectional
Al Daghri,
2010- Riyadh,
Saudi Arabia
[28]

118 children and adolescents,
Serum 25(OH)D: ELISA
non-obese, without chronic
SBP and DBP: average of 2
disease, not taking vitamin D
readings (not detailed)
supplements, recruited from
primary health care centers
Mean BMI (SD) in kg/m2: 118
children and adolescents, nonobese, without chronic disease,
not taking vitamin D supplements, recruited from primary
health care centers
Mean BMI (SD) in kg/m2: Boys:
19.8 (5.7); Girls: 18.9 (4.3)
% Male: 44.9%
Age in years: Range: 5–17;
Mean(SD): Boys: 12.4 (3.7); Girls:
11.6 (3.7)

None

Inverse correlation between
vitamin D with SBP and DBP
in the total sample and in
girls, but not in boys

Al Daghri,
2015- Riyadh,
Saudi Arabia
[29]

259 children, healthy, not
taking medications or
supplements known to affect
body weight, recruited from
primary health care centers
Mean BMI(SD) in kg/m2: Boys:
23.38 (6.23); Girls: 22.95 (4.97)
% Male: 39.8%
Age in years: Range: NR;
Mean(SD): Boys 14.9 (1.6); Girls
14.8 (1.6)

Serum 25(OH)D: COBAS e-411
automated analyzer
SBP and DBP: NR

None

● Inverse correlation
between vitamin D with SBP
in boys only
● Inverse correlation
between vitamin D with DBP
in the total sample

Al Daghri,
2015- Riyadh,
Saudi Arabia
[31]

2225 adolescents, healthy,
without acute or chronic
medical conditions, recruited
from private and public schools
Mean BMI(SD) in kg/m2: Boys:
22.9 (0.17); Girls: 23 (0.16)
% Male: 53.3%
Age in years: Range: 13–17;
Mean(SD): Boys: 15.1 (0.06);
Girls: 15.1 (0.06)

Serum 25(OH)D: COBAS e-411
automated analyzer
SBP and DBP: average of 2
readings, 15 min apart, by a
standardized mercury
sphygmomanometer

None

Inverse correlation between
vitamin D with SBP and DBP
in boys only

Al Daghri,
2016- Riyadh,
Saudi Arabia
[30]

4183 children, without acute
medical condition, with
information collected from a
biomarkers research program
Mean BMI(SD) in kg/m2: Boys:
21.4 (5.1); Girls: 22 (4.8)
% Male: 45.6%
Age in years: Range: 12–18;
Mean(SD): Boys: 14.3 (1.9); Girls:
14.3 (2.1)

Serum 25(OH)D: COBAS e-411
automated analyzer
SBP and DBP: NR

None

Inverse correlation between
vitamin D with SBP and DBP
in boys only

Al Daghri,
2018- Riyadh,
Saudi Arabia
[32]

740 adolescents, without
serious medical conditions, not
taking medications or vitamin
D supplements, recruited from
primary schools
Mean BMI(SD) in kg/m2: 21.9
(4.8)
% Male: 33.1%
Age in years: Range: 10–17;
Mean(SD): All: 14.2 (1.6); Boys:
14.1 (1.2); Girls: 14.3 (1.8)

Serum 25(OH)D: COBAS e-411
automated analyzer
Vitamin D status groups:
Deficient: 50–75 nmol/L;
Insufficient: < 50 nmol/L;
Sufficient: ≥ 75 nmol/L
SBP and DBP: NR

None

● No difference in SBP across
vitamin D status groups
● Lower DBP in vitamin D
sufficiency

Serum 1,25(OH)2D: ELISA
SBP and DBP: average of 2
readings (not detailed)

Gender and BMI

Inverse association between
vitamin D with SBP only

Al Saleh, 2013- 22 children with vitamin D
Riyadh, Saudi
deficiency, free of chronic
Arabia [35]
diseases, not taking vitamin D
supplements, recruited from
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Table 2 Characteristics and results of non-prospective cohort studies (Continued)
First author,
year- country

Study population

Outcomes evaluated and
evaluation method

Adjusted variables for
statistical analysis

Key findings

primary health care centers
Mean BMI(SD) in kg/m2: NR
% Male: 43.4%
Age in years: Range: NR;
Mean(SD): NR
Alemzadeh,
2012Wisconsin, USA
[33]

133 Caucasian, Hispanic and
African adolescents, obese (BMI
> 95th p for age), medically
stable, not taking medications
or multivitamin supplement,
recruited from an endocrine
clinic
Mean BMI(SD) in kg/m2: NR
% Male: 41.4%
Age in years: Range: 13.1–17.9;
Mean(SD): 14.9 (1.4)

Serum 25(OH)D:
radioimmunoassay
Vitamin D status groups:
Deficient: < 50 nmol/L;
Sufficient: ≥ 50 nmol/L
SBP and DBP: average of 2
readings, in sitting position

None

● No differences in SBP and
DBP across vitamin D status
groups
● No correlation between
vitamin D with SBP and DBP

Alemzadeh,
2016Wisconsin, USA
[34]

152 Caucasian, Hispanic and
African adolescents, obese (BMI
> 95th p for age), without
chronic medical conditions, not
taking supplements, recruited
from a children hospital
Mean BMI(SD) in kg/m2: NR
% Male: 42.8%
Age in years: Range: 13.2-17.8;
Mean(SD): 14.7 (1.3)

Serum 25(OH)D:
radioimmunoassay
Vitamin D status groups:
Deficient: < 50 nmol/L;
Insufficient: 50–74.9 nmol/L;
Sufficient: ≥ 75 nmol/L
SBP and DBP: average of 2
readings, in sitting position

None

No differences in SBP and
DBP across vitamin D status
groups

Ashraf, 2011Birmingham,
USA [37]

80 Caucasian American and
African American postmenarchal adolescents, obese
(BMI > 95th p for age and gender), without chronic disease,
not taking supplements, recruited from weight management clinics
Mean BMI(SD) in kg/m2: NR
% Male: 0%
Age in years: Range: NR;
Mean(SD): African American:
14.3 (2.3), Caucasian American:
14.8 (2.3)

Serum 25(OH)D: liquid
chromatography-tandem mass
spectrometry
SBP and DBP: automated BP
cuff (not detailed)

BMI; Race

No correlation between
vitamin D with SBP and DBP

Ashraf, 2014Alabama, USA
[36]

47 European American and
African American postmenarchal adolescents, without
medical conditions, not taking
medications and supplements,
recruited from weight management clinics
Mean BMI(SD) in kg/m2: 23.3
(4.5)
%Male: 0%
Age in years: Range: 14-18;
Mean(SD): 15.9 (1.4)

Serum 25(OH)D: liquid
Age; Percent body fat; Race;
chromatography mass
Fasting insulin; Height
spectrometry
Free 25(OH)D and bioavailable
25(OH)D: calculated using
published formulas
SBP ad DBP: average of 2
readings, after a 5-min rest,
using the auscultatory method,
in supine position

No correlation between
vitamin D with SBP and DBP

Atabek, 2014Konya, Turkey
[38]

247 children and adolescents,
obese (BMI > 95 p for age and
gender), without chronic
disease, not taking medications,
recruited from an outpatient
endocrinology and diabetes
pediatric clinic
Mean BMI(SD) in kg/m2: NR
%Male: 47.3%
Age in years: Range: 8–16;
Mean(SD): 11.93 (2.77)

Serum 25(OH)D: mass
spectrometry
Vitamin D status groups:
Deficient:< 50 nmol/L
SBP and DBP: after a rest ≥ 10
min, using a standard mercury
sphygmomanometer

None

● No differences in SBP and
DBP across vitamin D status
groups
● Inverse correlation
between vitamin D with SBP
only

Bacha, 2019-

79 Hispanic, Black and White

Total 25(OH)D:

None

No differences in SBP and
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Table 2 Characteristics and results of non-prospective cohort studies (Continued)
First author,
year- country

Study population

Outcomes evaluated and
evaluation method

Texas, USA [40] American adolescents, not
engaging in a diet or physical
activity program, without
medical conditions, not taking
medications and supplements,
recruited through
advertisement in the
community and at a children’s
hospital
Normal weight:22.8%;
overweight with normal
glucose tolerance:38%;
overweight with prediabetes:
39.2%
%Male: 43%
Age in years: Range: NR;
Mean(SD): 15.4 (0.2)

electrochemiluminescence
assay
SBP and DBP: average of 7
readings, taken 10 min apart,
by an automated device

Banzato, 2014Verona, Italy
[41]

25(OH)D: chemiluminescent
method
SBP and DBP: average of 3
readings, on the left arm over
30 min, in sitting position,
using a mercury
sphygmomanometer

32 Caucasian children,
overweight and obese
(definition: NR), free of chronic
disease, not taking medications
or supplements, recruited from
a pediatric department
Mean BMI(SD) in kg/m2: 30.08
(3.18)
%Male: 65.6%
Age in years: Range: 7–16;
Mean(SD): 11.7(2.26)

Adjusted variables for
statistical analysis

Key findings
DBP across tertiles of vitamin
D

None

No differences in SBP and
DBP across tertiles of vitamin
D

Cabral, 2016514 adolescents from the
Porto, Portugal EPITeen, recruited from public
[42]
and private schools
BMI ≥ 95 p for age and
gender: 9.3%
% Male: 47.5%
Age in years: Range: 13;
Mean(SD): NR

Serum 25(OH)D:
BMI; Gender; Parental
chemiluminescence
education; Physical activity;
immunoassay
Season
SBP and DBP: average of 2
readings separated by ≥ 5 min,
after a 10-min rest, by a mercury sphygmomanometer

● No differences in SBP and
DBP across quartiles of
vitamin D
● No difference in vitamin D
level among normotensive
and those with high BP

Cheraghi,
2012- Kansas,
USA [43]

74 white and non-white children with multiple, modifiable
atherosclerosis-promoting risk
factors, recruited from a preventive cardiology clinic at a
children's hospital
BMI > 95 p for age and gender:
85%
%Male: 44.6%
Age in years: Range: NR;
Mean(SD): 13.7 (3.1)

Serum 25(OH)D: NR
Vitamin D status groups:
Deficient: < 49.92 nmol/L;
Sufficient: ≥ 49.92 nmol/L
SBP: over the right arm, in
sitting position, using a
dinamap monitor

None

● No difference in SBP across
vitamin D status groups
● No difference in vitamin D
level among those with
normal and high SBP

Choi, 2014South Korea
[44]

260 adolescents, free of
diabetes, recruited from a rural
high school
Mean BMI(SD) in kg/m2: Boys:
22.2 (3.2); Girls: 21.2 (2.5)
%Male: 51.9%
Age in years: Range: 15–16;
Mean(SD): 15.9 (0.3)

Serum 25(OH)D:
radioimmunoassay
SBP and DBP: average of 2
readings, at rest, using a
oscillometric device with
appropriate cuff size

None

No correlation between
vitamin D with SBP and DBP

De Moraes,
2014European
Countries [45]

1089 European adolescents
from the HELENA study,
recruited from different
European countries
Mean BMI(SD) in kg/m2: Boys:
21.4; Girls: 21.3
%Male; 46.7%
Age in years: Range: 12.5–17.5;
Mean: 14.8

Plasma 25(OH)D: immunoassay
ELISA
SBP and DBP: lowest of 2
readings, taken 10 min apart, in
sitting position, using an
oscillometric monitor device

Contextual variables
No association between
(seasonality; latitude of
vitamin D with SBP and DBP
residence; school); Potential
individual confounders
(maternal education; age at
menarche (in girls); BMI; waist
circumference; physical activity;
serum lipid concentrations);
Biomarker serum concentrates
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Table 2 Characteristics and results of non-prospective cohort studies (Continued)
First author,
year- country

Study population

Outcomes evaluated and
evaluation method

Adjusted variables for
statistical analysis

Key findings

(blood composition; iron status
indicators; multiple vitamins
including vitamin D)
● Lower SBP and DBP with
increasing tertiles of vitamin
D
● Higher prevalence of HTN
in the lowest tertile of
vitamin D compared with
the highest tertile
● Lower odds of elevated
SBP or DBP with increasing
tertiles of vitamin D

De piero
314 children, free of disease,
Belmont, 2015- not taking medications and
Spain [46]
supplements, recruited from
public schools
Mean BMI(SD) in kg/m2: 19.4
(3.2)
%Male: 50.3%
Age in years: Range: 8–13;
Mean (SD): 10.7 (1.0)

Plasma 25(OH)D:
immunochemiluminescence
SBP and DBP: average of 3
reading, taken 5 min apart
using the right arm, in sitting
position
HTN status: Normal BP: SBP or
DBP ≤ 90th p; Pre-HTN: SBP or
DBP ≥ 90th p and ≤ 95 thp;
High BP: SBP or DBP ≥ 95th p

Dura-Trave,
2020Pamplona,
Spain [47]

236 Caucasian adolescents,
with severe obesity (BMI zscore > 3.0 or BMI > 99th p),
without illness, not taking
medication, vitamin D, or
calcium supplements
Mean BMI z-score(SD):
deficiency: 4.3 (1.1);
insufficiency: 4.4 (0.9);
sufficiency: 3.8 (0.6)
%Male: 62.3%
Age in years: Range: 10.2–15.8;
Mean: 13.4

Plasma 25(OH)D: high-specific
None
chemiluminescence
immunoassay
Vitamin D status group:
Deficient: < 50 nmol/L;
hypovitaminosis D: < 75 nmol/L
SBP and DBP: lowest of 3
measurements, in the right
arm, in supine position, using a
digital BP monitor
Arterial HTN: SBP and/or DBP ≥
95th p for age, sex, and height,
according to the American
reference charts (SBP > 130 or
DBP > 85 mmHg)

● Higher SBP and DBP with
vitamin D deficiency
● Higher prevalence of
arterial HTN with
hypovitaminosis D
● Inverse association
between vitamin D with SBP
only

Ganji, 2011USA [15]

5867 White, Black and Hispanic
children and adolescents,
recruited from the NHANES
study (2001–2006)
Mean BMI(SD) in kg/m2: 23.1
(0.1)
%Male: 50.6%
Age in years: Range: 12–19;
Mean: 15.4

Serum 25(OH)D:
radioimmunoassay
SBP and DBP: mercury
sphygmomanometer (not
detailed)

For SBP: Age; Sex; Race/
ethnicity; BMI
For DBP: Age; Sex

● Lower SBP with increasing
tertiles of vitamin D
● No association between
vitamin D with DBP

Ghobadi, 2019- 240 children, without chronic
Shiraz, Iran [48] disease, not on special diets,
not taking drugs affecting
metabolic status, recruited from
elementary schools
Mean BMI(SD) in kg/m2: 16.05
(2.74)
%Males: 52.9%
Age in years: Range: 6–9;
Mean(SD): 7.8 (1.06)

Serum 25(OH)D: ELISA
SBP and DBP: average of 2
readings, by mercury
sphygmomanometer

Age; Gender; BMI;
Physical activity

Inverse association between
vitamin D with SBP and DBP

Ha, 2013Suwon, South
Korea [50]

310 children, free of disease
not taking medications,
recruited from elementary
schools.
Mean BMI(SD) in kg/m2; serum
25(OH)D Q1: 19.8 (3.7); Q2: 19.4
(3.7); Q3: 19.3 (3.3); Q4: 18.3 (3)
%Male: 52%
Age in years: Range:10–12;
Mean (SD): Q1: 12.2 (1.2); Q2:
12.2 (1.3); Q3: 12.3 (1.1); Q4:12.3
(1.1)

Serum 25(OH)D:
chemiluminescence
immunoassay
SBP and DBP: average of 2
readings by an automated BP
instrument

Age; Gender; Tanner stage;
Body fatness; physical activity

● No differences in SBP and
DBP across quartiles of
vitamin D
● No association between
vitamin D with SBP and DBP

Hannesdottir,
2017- Iceland
[51]

159 elementary school children
Mean BMI(SD) in kg/m2: NR
%Male: 46.5%
Age in years: Range:7

Serum 25(OH)D:
radioimmunoassay
Vitamin D status groups:
Deficient: < 50 nmol/L;
Sufficient: > 50 nmol/L

None

● No association/correlation
between vitamin D with SBP
and DBP
● No differences in SBP and
DBP across vitamin D status

For the OR: Age; gender
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Table 2 Characteristics and results of non-prospective cohort studies (Continued)
First author,
year- country

Study population

Outcomes evaluated and
evaluation method

Adjusted variables for
statistical analysis

SBP and DBP: average of 3
readings in a standard way
using the left arm
Hassan, 2015Egypt [52]

65 obese (BMI > 95th p for age
and sex-specific growth curves)
and 30 healthy (BMI between
15 and 85th p for age and sexspecific growth curves) children
with no medical conditions, including type I and type II diabetes, not taking any
medications that influence
physical growth, recruited from
primary public schools
Mean BMI(SD) in kg/m2: 24.28
(5.95)
%Male: 49.5%
Age in years: Range: 8–11;
Mean(SD): All: 9.99 (1.14);
obese:10.1 (1.18) ; control: 10.27
(0.74)

Key findings
groups

Serum 25(OH) D: NR
SBP and DBP: average of 2
readings by a mercury
sphygmomanometer after a
rest of 20 min

None

No association between
vitamin D with SBP and DBP
in the total sample, and in
obese participants

Hirschler, 2012- 116 boys without chronic
Buenos Aires,
disease, and not taking
Argentine [53] medications known to affect
bone metabolism, recruited
from amateur rugby club
Mean BMI (SD) in kg/m2: 22.0
(5.3)
%Male: 100%
Age in years: Mean(SD): 11.3
(2.4)

Serum 25(OH)D:
radioimmunoassay kit
SBP and DBP: NR

Tanner stage

No differences in SBP and
DBP across quartiles of
vitamin D

Hirschler, 2013- 290 Indian Koya children, free
Buenos Aires,
of chronic disease, recruited
Argentine [54] from schools
Mean BMI in kg/m2: 16.88
(2.99)
%Male: 44.5%
Age in years: Range: 5–19;
Mean(SD): 10.7(2.9)

Serum 25(OH)D:
radioimmunoassay kit
Vitamin D status groups:
Deficient: < 50 nmol/L
SBP and DBP: NR

Age (adjustment only for SBP
across quartiles)

● Higher SBP and DBP with
vitamin D deficiency
● Lower SBP with increasing
quartiles of vitamin D

Hirschler, 2019San Antonio
de los Cobres
and Chicoana,
Argentine [55]

Serum 25(OH)D:
Age; Gender; z-BMI; Milk intake
radioimmunoassay
SBP and DBP: average of 2
readings, at a period of 1 to 2
min, by a mercury
sphygmomanometer in a
sitting position with the child’s
right forearm horizontal on the
table and cuffs sizes adjusted
for differences in arm
circumference and height
HTN: average of the values of
SBP and /or DBP ≥ 95th p
based on age , sex and height
p

Inverse association between
vitamin D with SBP and DBP

Serum 25(OH)D:
BMI; Age; Sex; Location;
radioimmunoassay
Triglycerides; Insulin; Glucose
SBP and DBP: average of 2
readings at a period of 1 to 2
min by a mercury
sphygmomanometer in a
sitting position, with the child’s
right forearm horizontal on the

No association between
vitamin D with SBP, DBP and
MAP

152 indigenous schoolchildren
from San Antonio de los
Cobres;175 from Chicoana not
taking medications affecting
BP, lipids, glucose level, with
no significant difference in
socioeconomic level, age, BMI
and waist circumference,
recruited from elementary
schools
Mean BMI(SD): San Antonio de
los Cobres in kg/m2: 16.83
(2.69); Chicoana: 19.27 (4.41)
%Male: 51.7%
Age in years: Mean(SD) San
Antonio de los Cobres: 9.37
(2.11); Chicoana: 9.02 (2.14)

Hirschler, 2019- 152 indigenous schoolchildren
Argentine [56] from San Antonio de los
Cobres;175 from Chicoana not
taking medications affecting
BP, lipids, glucose level, with
no significant difference in
socioeconomic level, age, BMI
and waist circumference,
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Table 2 Characteristics and results of non-prospective cohort studies (Continued)
First author,
year- country

Study population

Outcomes evaluated and
evaluation method

Adjusted variables for
statistical analysis

Key findings

recruited from elementary
schools Mean BMI(SD): San
Antonio de los Cobres in kg/
m2: 16.83 (2.69); Chicoana:
19.27 (4.41)
%Male: 51.7%
Age in years: Mean(SD) San
Antonio de los Cobres: 9.37
(2.11); Chicoana: 9.02 (2.14)

table and cuffs sizes adjusted
for differences in arm
circumference and height
MAP: (DBP*2 + SBP) / 3

Izadi, 2020Tehran, Iran
[57]

514 students, without disease,
or regular use of medication or
supplement, recruited from
local schools
Mean BMI(SD) in kg/m2: 17.41
(0.19)
% Male: 46.69%
Age in years: Range: 7–12;
Mean(SD): 9.16 (1.53)

Serum 25(OH)D: ELISA
Linear regression; Age; BMI;
No association between
SBP and DBP: standard mercury Gender; DBP; Triglycerides; HDL vitamin D with SBP, in
pressure gauge with
and Total Cholesterol
adjusted model
dimensions suitable for
children and standard medical
devices in a sitting position
after a 5-min rest

Jang, 2013South Korea
[58]

320 adolescents, not taking
medications and not having
high insulin levels, recruited
from schools as part of the
Korean Children Adolescent
Study
Not-overweight: 88.4%;
Overweight: 11.5%
% Male: 0%
Age in years: Range: 12.4–14.5;
Mean(SD): NR

Serum 25(OH)D: gamma
counter with a
radioimmunoassay
Vitamin D status: Deficient: <
50 nmol/L
SBP and DBP: average of 2
readings by a mercury
sphygmomanometer in a
sitting position at rest
High BP: ≥ 130/85 mmHg

BMI z-score; Physical activity

● No correlation between
vitamin D with SBP and DBP
● Higher SBP with vitamin D
deficiency
● No differences in
prevalence of HTN and DBP
across vitamin D status
groups

Kardas, 2013Turkey [59]

114 children and adolescents
obese (BMI ≥ 90th p for
reference curves for Turkish
children) and non-obese recruited from a children hospital
Mean BMI(SD) in kg/m2: 24.5
(5.4); Mean BMI (obese): 28.5
(2.7); Mean BMI (non-obese);
19.6 (3.6)
% Male: 50.9%
Age in years: Mean(SD) obese:
13.5 (1.6); non-obese 13.4 (1.7)

Plasma 25(OH)D: HPLC
SBP and DBP: average of 2
readings by a mercury
sphygmomanometer, after a
20 min rest

None

Inverse correlation between
vitamin D with SBP and DBP
in the total sample; no
longer significant when
assessed among obese and
non-obese participants

Kelishadi,
2014-Iran [61]

1095 nationally representative
sample of Iranian students
Mean BMI(SD) in kg/m2: 19.37
(4.58)
% Male: 52%
Age in years: Range: 10–18;
Mean(SD): 14.74 (2.61)

Serum 25(OH)D:
chemiluminescence
immunoassay
SBP and DBP: average of two
readings by a standardized
mercury sphygmomanometer
in a sitting position on the
right arm with an appropriate
cuff size

Age; Gender; Anthropometric
measures

Inverse association between
vitamin D with SBP and DBP

Khadgawat,
2012- New
Delhi, India
[62]

62 obese Asian-Indian children
and adolescents without any
known systemic illness, endocrine or metabolic disorder or
symptoms suggesting hypothalamic obesity, not taking
any medications.
Mean BMI(SD) in kg/m2: 29.3
(4.8)
% Male: 56.5%
Age in years: Range: 6–17;
Mean(SD): 13 (3.1)

Serum 25(OH)D:
BMI; Age; Gender; Pubertal
radioimmunoassay
stage
Vitamin D status groups:
Deficient:< 50 nmol/L; Severe;
Deficiency: < 12.5 nmol/L;
Moderate Deficiency: 12.5–25
nmol/L; Mild Deficiency :25–50
nmol/L
SBP and DBP: average of 3
readings in a sitting position,
after a 5 min rest ,by a mercury
sphygmomanometer in the
right upper arm with an
appropriate size cuff

No differences in SBP and
DBP across vitamin D status
groups
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Table 2 Characteristics and results of non-prospective cohort studies (Continued)
First author,
year- country

Study population

Outcomes evaluated and
evaluation method

Adjusted variables for
statistical analysis

Kim, 2018South Korea
[64]

2314 adolescents selected from
the KNHANES (2010–2014)
nationwide survey who were
fasting for more than 8 h, and
had complete data for 25(OH)D
and metabolic syndrome
components
Mean BMI(SD) in kg/m2: NR
% Male: 53.80%
Age in years: Range: 12–18;
Mean(SD): NR

Serum 25(OH)D: NR
Vitamin D status groups:
Deficient: < 50 nmol/L;
Sufficient: ≥ 50 nmol/L
SBP and DBP: average of 3
readings on the right arm after
a 5-min rest
Elevated BP: SBP ≥ 130 mmHg;
DBP ≥ 85 mmHg

Age; Gender; Household
Similar odds of elevated BP
income; Residential area; Selfacross vitamin D status
perceived health status; Selfgroups, in adjusted model
perceived stress status; family
history of chronic disease;
Sleep habits, and physical activity habits

Kumar, 2009USA [65]

9757 non-Hispanic white, nonHispanic black, Hispanics/Mexicans and other race; children
and adolescents from the
NHANES study (2001–2004)
Mean BMI(SD) in kg/m2: NR
% Male: NR
Age in years: Range: 1–21;
Mean(SD): NR

25(OH)D: diasorin assay
Vitamin D status groups:
Deficient:< 37.5 nmol/L;
Insufficient: 37.5–72.5 nmol/L
SBP and DBP: average of 3
readings
HTN: SBP or DBP >95th p for
the median height of each
participant's age and gender or
> 140/90 mmHg in those ≥ 17
years of age

Age; Gender; Race/ethnicity;
Poverty income ratio; Obesity;
Milk intake; Television and
computer use; vitamin D
supplement use

Lee, 2014Seoul, South
Korea [14]

1660 children from the
KMOSES, no history of
cardiovascular disease,
diabetes, HTN or endocrine
disorders, non-smoking, no alcohol consumption
Mean BMI(SD) in kg/m2: Boys:
8.6 (3.4) Girls: 17.4 (3.0)
% Male: 54.5%
Age in years: Range: 9;
Mean(SD): NR

Serum 25(OH)D:
BMI
chemiluminescent
immunoassay
SBP and DBP: standard brachial
cuff technique.
HTN: > 90th p for sex, height
and age

● No differences in
prevalence of high BP, SBP
and DBP across quartiles of
vitamin D
● No difference in vitamin D
level among normotensive
and those with high BP

Lee, 2015Seoul, South
Korea [68]

2880 children and adolescents
from the KNHANES (2008–
2010) nationwide survey
having data on 25(OH) D levels
and blood sample for
metabolic syndrome
components
Mean BMI(SD) in kg/m2: 20.46
(3.57)
%Male: 53.4%
Age in years: Range:10–18;
Mean(SD): 13.74 (2.49)

25(OH)D: 125I-labelled radioimmunoassay kits
SBP and DBP: average of 2
readings in the right arm,
within 5 min interval, by a
standard mercury
sphygmomanometer at rest.

Age; Gender

Lower SBP and DBP with
increasing quartiles of
vitamin D

Lee, 2016- USA 209 non-Hispanic white, non[69]
Hispanic black, other race, overweight or obese patients recruited to participate in the
OSCIR if having insulin resistance, depressed fasting glucose
to fasting insulin ratio or referral from primary health clinics
and free of chronic or acute infectious diseases, not taking
glucose or lipid lowering
medications.
Mean BMI(SD): 35.9 (8.4)
%Male: 45%
Age in years: Range: 6–18;
Mean(SD): 12.6 (2.9)

Plasma total 25(OH)D: in
duplicates by
Immunodiagnostic Systems
enzyme immunoassay
SBP and DBP: standard
sphygmomanometer in a
sitting position with an
appropriate size cuff

None

No association between
vitamin D with SBP and DBP

Malyavskaya,
2017- Russia
[108]

Serum 25 (OH)D: ELISA
SBP and DBP: NR

None

● No differences in SBP and
DBP across quartiles of
vitamin D, except for a

319 children and adolescents,
without acute and/or chronic
diseases, recruited from

Key findings

● Higher odds of HTN with
vitamin D deficiency
● Higher SBP and DBP with
poorer vitamin D status
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Table 2 Characteristics and results of non-prospective cohort studies (Continued)
First author,
year- country

Study population

Outcomes evaluated and
evaluation method

Adjusted variables for
statistical analysis

secondary educational
institutions
Mean BMI(SD) in kg/m2: Q1:
22.6 (4.2); Q2: 20.8 (4.7); Q3:
20.2 (4.4); Q4: 19.6 (3.4)
%Male: 51%
Age in years: Range:10–15;
Mean(SD): 13.3 (1.6)

Key findings
higher DBP for Q 1 vs. 4
● Inverse correlation
between vitamin D with DBP
only

Matter, 2016KSA [72]

84 healthy adolescents
attending an outpatient clinic,
without acute or chronic
disease or under treatment
that could influence 25(OH)D
level, and with 25(OH)D levels
of < 50 or > 75 nmol/L
Mean BMI(SD): NR
% Male deficient group: 60%;
control group:72%
Age in years: Range: 12–16;
Mean(SD) deficient group:
14.08 (2.01); control group:
13.93 (1.06)

Serum 25(OH)D:
radioimmunoassay
Vitamin D status: Deficient: <
50 nmol/L
SBP and DBP: NR

None

No differences in SBP and
DBP across vitamin D status
groups

Mellati, 2015Iran [73]

297 healthy schoolchildren
Mean BMI(SD) in kg/m2: 17.81
(3.39)
% Male: 45.10%
Age in years: Range: 7–11 ;
Mean(SD): 7.86 (1.32)

Serum 25(OH)D: ELISA using
immunodiagnostic system
SBP and DBP: average of 3
readings in 10 min intervals
after at least a 15-min rest. For
those with higher BP, the
measurement was repeated
on another day

None

● Lower SBP and DBP with
increasing tertiles of vitamin
D
● Inverse correlation
between vitamin D with SBP
and DBP

Milagres, 2017- 378 children from all public
Vicosa, Brazil
and private schools from the
[74]
Survey of Health Assessment of
Schoolchildren, not taking
medications interfering with
metabolism of vitamin D,
glucose, lipids, and no vitamin
mineral supplementation.
Mean BMI Z-score: 0·41 (1.4)
% Male: 47.8%
Age in years: Range: 8–9;
Mean(SD): NR

Serum 25(OH)D: architect 25OH vitamin D assay
Vitamin D status group:
Deficient: < 50 nmol/L;
Insufficient: ≥ 50–< 75 nmol/L;
Sufficient: ≥ 75 nmol/L
SBP and DBP: average of 3
readings by an automatic
inflation BP monitor in a sitting
position with at least a 5-min
rest
Elevated BP: SBP or DBP ≥ 90th
p for age, gender and height
according to the VI Brazilian
guidelines of HTN by the
Brazilian Society of Cardiology

Age; Gender; Season
Ethnicity; PTH; Per capita
income; Maternal schooling;
vitamin D intake; Sedentary
behavior; Percentage of body
fat (or other measures of
adiposity)

No difference in prevalence
of elevated BP and HTN
across vitamin D status
groups

Moore, 2017USA [75]

2908 children and adolescents
from the NHANES study (2007–
2010), not pregnant, and
completed 24-h recall
Mean BMI(SD) in kg/m2: NR
% Male: 51.4%
Age in years: Range: 8–18;
Mean(SD): NR

Serum 25(OH)D: LC/MS
Race/ethnicity; Sex; Age;
Vitamin D status group:
Economic status; BMI z-score
Deficient: < 50 nmol/L;
Insufficient: 50–72.5 nmol/L;
Sufficient :> 72.5 nmol/L
SBP and DBP: average of 3
readings by the auscultatory
method in a sitting position for
5 min
Normal BP: SBP or DBP < 90th
p for age, sex and height; PreHTN: SBP: ≥ 90th to < 95th p
for age, sex and height; HTN: ≥
95th p for age, sex and height

● No association between
vitamin D with SBP and DBP,
in adjusted model
● Higher prevalence of HTN
with poorer vitamin D status

Muhairi, 2013Al Ain, UAE
[76]

315 healthy adolescents (BMI:
5–75th p for age and sex), not
using regular medications or
have chronic medical

Serum 25(OH)D:
None
radioimmunoassay
SBP and DBP: average of 2
readings by a standard mercury

No difference in vitamin D
level among normotensive
and those with high BP
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Table 2 Characteristics and results of non-prospective cohort studies (Continued)
First author,
year- country

Study population

Outcomes evaluated and
evaluation method

Adjusted variables for
statistical analysis

Key findings

conditions that might affect
growth, body composition,
dietary intake or physical
activity and non-smokers, recruited from schools
obese:16.5%; Overweight :15.9;
Lean: 67.5%
% Male: 48%
Age in years: Range: 12–18;
Mean(SD): NR

sphygmomanometer after a 5min rest in a sitting position
with appropriate cuff size

Nam, 2012South Korea
[77]

713 adolescents from the
KNHANES (2007–2009),
nationwide survey not having
congenital heart disease or
previous diagnosis of epilepsy
Mean BMI (SD) in kg/m2: 21.12
(0.16)
% Male: 53.01
Age in years: Range: 12–19;
Mean(SD): NR

Serum 25(OH)D:
radioimmunoassay
SBP and DBP: average of 2
measurements in 5-min intervals, by standard mercury
sphygmomanometer on the
right arm

None

● No difference in SBP across
tertiles of vitamin D
● Lower DBP with increasing
tertiles of vitamin D

Nam, 2014South Korea
[78]

1504 adolescents from the
KNHANES (2008–2009),
nationwide survey, not having
congenital heart disease or
epilepsy
Mean BMI(SE): insufficient
group: 21.2 (0.1); sufficient
group: 20.4 (0.2)
% Males: 52.65%
Age in years: Range: 12–18;
Mean(SD): NR

Serum 25(OH)D:
radioimmunoassay
Vitamin D status groups:
Insufficient: ≤ 50 nmol/L;
Sufficient: > 50 nmol/L
SBP and DBP: average of 2
measurements in 5-min intervals, by standard mercury
sphygmomanometer on the
right arm
High BP: SBP or DBP ≥ 90th p
for age and sex, use of BPlowering medication or a previous diagnosis of HTN

For the OR between high BP
and 25(OH)D: Age; Gender;
BMI; Regular physical exercise;
Alcohol drinking; Use of
multivitamin or mineral
supplements

● Inverse correlation
between vitamin D with SBP
and DBP
● No difference in SBP across
vitamin D status groups;
higher DBP with vitamin D
insufficiency
● Similar odds of high BP
across vitamin D status
groups, in adjusted model

Nsiah-Kumi,
2012Nebraska, USA
[80]

198 native American healthy
youth (without active infection,
or illness that could affect
weight), recruited from schools,
local grocery store, tribal
exercise facility, health facilities,
community events
Mean BMI p: 78 (1.7)
% Male: 47%
Age in years: Range: 5–19;
Mean(SEM): 10.8 (0.3)

25(OH)D: radioimmunoassay
BMI p for age and sex
vitamin D status groups:
Deficient: < 40 nmol/L;
Insufficient: < 75 nmol/L
SBP and DBP: after a 5-min rest,
using an appropriately sized
cuff

Inverse association between
vitamin D with SBP and DBP

Nwosu, 2013Central New
England, USA
[81]

45 prepubertal healthy children
recruited using paper flyers
from primary care physician
offices
Normal weight: 44.4%;
Overweight: 55.6%
% Male: 58%
Age in years: Range: 3–12;
Mean(SD): 8.3 (2.5); Males: 9.0
(2.4); Females: 7.28 (2.4)

Serum 25(OH)D:
chemiluminescent
immunoassay
Vitamin D status groups:
Deficient:< 50 nmol/L;
Sufficient: > 50 nmol/L
SBP and DBP: NR

None

No differences in SBP and
DBP across vitamin D status
groups

Oliveira, 2014Juiz de Fora,
Brazil [83]

160 healthy adolescents not
using medications or
supplements, recruited from
schools
Normal weight: 48.1%;
Overweight: 51.9% (matched
for age, gender and type of
school)
% Male: 55.6%

Serum 25(OH)D:
radioimmunoassay
SBP and DBP: average of the
second and third
measurements, at 5-min intervals, with the right arm at the
same level as the heart, by an
equipment validated against
mercury sphygmomanometers

None

Lower vitamin D level
among hypertensive
participants
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Table 2 Characteristics and results of non-prospective cohort studies (Continued)
First author,
year- country

Study population

Outcomes evaluated and
evaluation method

Adjusted variables for
statistical analysis

Key findings

Age in years: Range: 15–17;
Mean(SD): 16 (0.9)

according to the international
validation protocol, using an
appropriate cuff size, in a sitting position
Elevated BP: based on
parameters of the Brazilian HTN
Society taking into account
gender, age and height

Olson, 2012North Texas,
USA [84]

411 obese (BMI ≥ 95th p for
age) children without disease,
not using medications or
vitamin D supplement > 400
IU/day, recruited from an
obesity center at a children’s
medical center
Mean BMI(SD) in kg/m2: NR
% Male: 43%
Age in years: Range: 6–16;
Mean(SD): 11.7(2.6)

25(OH)D: chemiluminescent
immunoassay
SBP and DBP: average of up to
3 measures, by dinamap
procare monitor, at rest

BMI z-scores; Age

No correlation between
vitamin D with SBP and DBP

Pacifico, 2011Rome, Italy
[85]

452 healthy children recruited
from outpatient clinics
%Male Tertile 1: 49.4%; Tertile 2:
45%; Tertile 3: 45.6%
Overweight/obese: 67.25%
Age in years: Median(IQR):
Tertile 1: 11.5 (4.2); Tertile 2:
11.2 (4.3); Tertile 3: 11.0 (4.0)

Serum 25(OH)D3:
electrochemiluminescence
immunoassay
SBP and DBP: average of 2
measures, at the right arm in
the supine position using an
automated oscillatory system,
after a 10-min rest
Elevated BP: SBP or DBP ≥ 90th
p for age, gender and height

For correlation: age; gender;
Tanner stage
For regression:
Model 1: age; gender; Tanner
stage
Model 2: age; gender; Tanner
stage; waist circumference
Model 3: age; gender; Tanner
stage; Standard deviation
score-BMI

● Lower SBP and DBP with
increasing tertiles of vitamin
D
● Negative correlation
between vitamin D with SBP
only
● Lower odds of elevated BP
with increasing tertiles of
vitamin D, in adjusted model

Parikh, 2012Augusta area,
USA [86]

701 healthy adolescents, not
taking medications, recruited
from high schools
Mean BMI(SD) in kg/m2: 23.0
(4.7)
Age in years: Range: 14–18;
Mean(SD): 16.2 (1.2)

Plasma 25(OH)D: liquid
chromatography tandem mass
spectroscopy
SBP and DBP: NR

Age; Gender; Ethnicity; Sexual
maturation; Season;
Physical activity;
Percent body fat

● Inverse correlation
between vitamin D with SBP
and DBP
● Lower SBP with increasing
tertiles of vitamin D; No
difference in DBP

Petersen, 2015- 782 healthy children, not taking
Denmark [87] medications, recruited from
schools
Girls: Obese: 2%; Overweight:
13%; Normal weight: 74%;
Underweight: 11%
Boys: Obese: 2%; Overweight:
11%; Normal weight: 78%;
Underweight: 9%
Age in years: Range: 8–11;
Mean(SD): Boys: 10.1 (0.6); Girls:
9.9 (0.6)

Serum 25(OH)D (including both
D2 and D3): automated
chemiluminescent
immunoassay
SBP and DBP: average of 3
readings, after 10-min rest, by
an automated device, using
two different cuff sizes

Sex; Age; Height; Ethnicity;
Whole-blood EPA+ DHA; Entered puberty (yes/no); Parental
education

● No association between
vitamin D with SBP
● Inverse association with
DBP, in adjusted model

Pirgon, 2013Turkey [88]

87 obese adolescents, recruited
from a pediatric endocrinology
unit: 45 patients with NAFLD
and 42 patients without NAFL
D, not taking medications, and
free of other diseases
Mean BMI(SD) in kg/m2: 2.1
(0.3)
% Male: 48.2%
Age in years: Range: 11–15;
Total: Mean(SD): 12.7 (1.3);
NAFLD group:12.8 (0.8); NonNAFLD group:12.6 (1.7)

Serum 25(OH)D: automated
chemiluminescence
immunoassay
SBP and DBP: mercury-gravity
manometer and a cuff appropriate for body size, in a sitting
position, after rest for at least 5
min

None

No correlation between
vitamin D with SBP and DBP
in participants with and
without NAFLD

Prodam, 2016Novara area,
Italy [89]

575 healthy, overweight or
obese, sedentary children and
adolescents (according to

Serum 25(OH)D: direct
competitive chemiluminescent
immunoassay

None

Inverse correlation between
vitamin D and SBP only
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Table 2 Characteristics and results of non-prospective cohort studies (Continued)
First author,
year- country

Study population

Outcomes evaluated and
evaluation method

Adjusted variables for
statistical analysis

Key findings

International Obesity Task
Force criteria), not using
medications, recruited from a
pediatric endocrinology clinic
Mean BMI (SD) in kg/m2: 26.7
(4.5)
Severely obese: 27.6%; Obese:
44.2%; Overweight: 28.2%
% Male: 50.26%
Age in years: Range: 6–18;
Mean(SD): 10.7(2.8)

SBP and DBP: average of 3
measurements on the left arm,
after a 15-min rest in the supine position and prior to
other physical evaluations,
using a standard mercury
sphygmomanometer

Rafraf, 2014Boukan, Iran
[90]

216 healthy adolescents, not
using medication or
supplements, recruited from
high schools
Mean BMI(SD) in kg/m2: 21.1
(3.5)
% Male: 0%
Age in years: Range: 14–17;
Mean(SD): 15.9 (1.0)

Serum 25(OH)D: ELISA
SBP and DBP: average of 2
measurements, at a 1–2 min
interval, in the morning by a
mercury sphygmomanometer
with an adult cuff on the
upper right arm, with the arm
horizontally on a table, in the
sitting position, after a 5-min
rest

BMI; Energy; Physical activity
level

No association between
vitamin D with SBP and DBP

Reis, 2009USA [91]

3528 adolescents nationally
representative sample of white,
black, Mexican American and
other race (NHANES 2001–
2004) not diabetic, not
pregnant
Mean BMI(SD) in kg/m2: NR
% Male: 51.5%
Age in years: Range: 12–19;
Mean(95%CI): 15.4 (15.3–15.6)

Serum 25(OH)D:
radioimmunoassay
SBP and DBP: average of up to
4 measures by a mercurygravity sphygmomanometer
using appropriate arm cuff size,
in seated position, after a 5min rest
High BP: SBP or DBP ≥ 90th p
for age, sex, and height, or use
of BP medications

Age; Gender; Ethnicity; BMI
Poverty-to-income ratio;
Physical activity
No adjustment for vitamin D as
outcome

● Lower prevalence of high
BP and SBP with increasing
quartiles of vitamin D; No
difference in DBP
● Lower vitamin D level
among participants with
high BP

Simpson, 2020- 203 healthy, urban-dwelling
Connecticut,
children, not using medications
USA [92]
or vitamin D supplements >
400 IU/day, recruited to participate in a vitamin D supplementation study from local medical
offices and community site
Mean BMI(SD) in kg/m2: NR
% Male: 50.24%
Age in years: Range: 6 months–
10 years; Mean(SD): 5.6 (2.3)

Total serum 25-OHD and 1,
None
25(OH)2D: radioimmunoassay
Calculated free 25(OH)D:
calculated using serum vitamin
D binding protein and albumin
concentrations, and their
reported dissociation constants
Genotype-specific free
25(OH)D: calculated using
25(OH)D/DBP dissociation
constants specific for each
individual’s haplotype
Direct measured free 25(OH)D:
ELISA
SBP and DBP: NR

Inverse correlation between
vitamin D with SBP only

Skrzypczyk,
2018- Poland
[93]

49 children and adolescents
with primary HTN, not using
vitamin D supplements during
last 12 months
Obese: 30.6%; Overweight:
28.6%
% Male: 69.4%
Age in years: Range: 5.58–18;
Mean(SD): 14.29 (3.17)

25(OH)D: chemiluminescence
Peripheral BP: using
oscillometric device
24-h BP: using a SUNTECH
OSCAR 2 device and
interpreted according to the
American Heart Association
guidelines. Monitors were
programmed to measure BP
every 15 min from 6 AM to 10
PM and every 30 min from 10
PM to 6 AM.
SBP, DBP and MAP: measured
during 24 h

None

No correlation between
vitamin D with SBP and DBP

Teixeira, 2018Rio de Janeiro,
Brazil [96]

60 severely obese adolescents
(BMI > 99.9th p for age),
without chronic disease, not

Serum 25(OH)D: HPLC
Vitamin D status group:
Deficient: ≤50 nmol/L;

None

No difference in prevalence
of HTN across vitamin D
status groups
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Table 2 Characteristics and results of non-prospective cohort studies (Continued)
First author,
year- country

Adjusted variables for
statistical analysis

Key findings

25(OH)D: in duplicate, using
the LIASON 25-OH vitamin D
total assay
Vitamin D status group:
Deficient: < 50 nmol/L; Nondeficient: ≥ 50 nmol/L
SBP and DBP: median of 3
measurements, after 5-min rest,
using the right arm and in the
seated position
MAP: 1/3 SBP + 2/3 DBP

Overweight status; Age; Sex;
Height; Seasonality; Personal
smoking status; Second-hand
smoke exposure; Monthly
household income; Study site

Higher MAP, SBP, DBP with
vitamin D deficiency

Valle, 2019- Rio 97 overweight (BMI ≥ 85th p)
de Janeiro,
and obese adolescents (BMI ≥
Brazil [98]
95th p), cared for in the NESA,
free of chronic disease, not
taking medications or
supplements
Mean BMI(SD) in kg/m2: 32.2
(6.3)
%Male: 44%
Age in years: Range: 12–19;
Mean(SD): 14.7 (1.8)

Serum 25(OH)D: HPLC
Vitamin D status group:
Deficient: < 50 nmol/L
SBP and DBP: by an automatic
inflation BP monitor (not
detailed)
High BP: NR

None

● Inverse association
between vitamin D with DBP
only
● Higher prevalence of
elevated BP with vitamin D
deficiency
● Higher SBP with vitamin D
deficiency

Williams, 2011- Nationally representative
USA [100]
sample of healthy adolescents
(NHANES 2001–2006) [N for
25(OH)D: 6013; SBP: 4807; DBP:
4777]
% Male: Quintile 1: 40.7%;
Quintile 2: 52.9%; Quintile 3:
53.7%; Quintile 4: 54.6%;
Quintile 5: 54.6%
Age in years: Range: 12–19;
Mean(95%CI): Quintile 1: 15.7
(15.5, 15.9); Quintile 2: 15.1
(14.9, 15.3), Quintile 3: 14.9
(14.7, 15.2); Quintile 4: 15.2
(15.0, 15.5); Quintile 5: 15.6
(15.4, 15.8)

Serum 25(OH)D:
radioimmunoassay
SBP and DBP: average of up to
4 measurements, at rest

Age; Gender; Ethnicity; Poverty
income ratio; Waist
circumference; Sampling
probability (via weights);
Cluster effects

Inverse association between
vitamin D and SBP only

Wojcik, 201730 obese adolescents recruited
Krakow, Poland from a children’s university
[104]
hospital
Mean BMI(SD)in kg/m2: 32.5
(4.85)
% Male: 46.66%
Age in years: Range: NR;
Mean(CI): 13.23 (12.64–13.8)

Serum 25(OH)D: HPLC
Vitamin D status group:
Deficient: < 50 nmol/L
SBP and DBP: average of 3
measurements, every 3 min,
using a pneumatic
sphygmomanometer
Arterial HTN: mean SBP and/or
DBP >95th p for age, height
and gender

None

Higher prevalence of arterial
HTN and DBP with vitamin D
deficiency; no difference in
SBP

Xiao, 2020China [105]

Plasma 25(OH)D:
chemiluminescent
immunoassay
Vitamin D status group:
Adequacy: < 50 nmol/L;
Inadequacy: > 50 nmol/L

Age; Gender; Season of blood Higher odds of HTN with
collection; Geographical
vitamin D inadequacy, in the
location; Smoking; Drinking;
total sample and in girls only
Physical activity; Dietary
vitamin D intake; BMI; Fat mass
percentage; Muscle mass index

Tomaino,
2015- Lima
and Tumbes,
Peru [97]

Study population

Outcomes evaluated and
evaluation method

taking medications or vitamin
D supplementation, recruited
from an obesity clinic
Mean BMI(SD) in kg/m2: 46.21
(7.01)
% Male: 36.7%
Age in years: Range: 10–20;
Mean(SD): 17.32 (1.35)

Insufficient: > 50– < 75 nmol/L;
Adequate: 75–247 nmol/L
SBP and DBP: average of 2
measures taken 1 min apart, by
oscillometric technique semiautomatic digital arm device,
after a 5-min rest
HTN: according to the VI
Brazilian Guidelines for HTN in
adolescents

1074 adolescents selected from
a community census
Mean BMI in kg/m2: 21.2
Overweight (based on standard
recommendations for age- and
sex-specific body mass index
cutoffs for international, adolescent populations): 22%
% Male:48%
Age in years: Range: 13–15;
Mean(SD): 14.9 (0.8)

6091 nationally representative
sample of children and
adolescents, without any
condition, or use of drug
affecting cardiovascular health,
recruited from schools
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Table 2 Characteristics and results of non-prospective cohort studies (Continued)
First author,
year- country

Study population

Outcomes evaluated and
evaluation method

Adjusted variables for
statistical analysis

Mean BMI(SD) in kg/m2: NR
% Male:50.2%
Age in years: Range: 6–18;
Mean(SD): 11.9 (3.7)

SBP and DBP: average of last 2
reading out of 3, with 1–2 min
intervals, after resting for at
least 15 min, in a sitting
position from the right arm
using a suitable cuff size based
on the arm circumference
HTN: average SBP and/or DBP
≥ 95th sex, age and heightspecific p for Chinese children
and adolescents, or taking antihypertensive drugs

Yousefichaijan,
2019- Arak,
Iran [106]

65 healthy children, without
disease, not taking
hypertensive drugs, with
vitamin D deficiency, recruited
from a hospital
Mean BMI(SD) in kg/m2: 16
(2.84)
% Male: 49.2%
Age in years: Range < 11;
Mean(SD): 13.9 (3.2)

Serum 25(OH)D: NR
None
Vitamin D status group:
Deficient: < 50 nmol/L
SBP and DBP: digital monitor
citizen
Hypertensive status: Normal: BP
< 90th p for age, gender and
height; Pre-HTN: BP: 90–95th p;
Stage 1 HTN: BP: 95–99th p +
5 mmHg; Stage II HTN: BP:
>99th pe + 5 mmHg

Zhou, 2011USA [107]

140 healthy obese (BMI > 95th Serum 25(OH)D:
p for age and gender) children, chemiluminescent assay
SBP and DBP: NR
recruited from a pediatric
endocrine clinic
2
Mean BMI(SD) in kg/m : 34.5
(7.4)
% Male: 40.7%
Age in years: Range: 6–21;
Mean(SD): 13.9 (3.2)

Key findings

No difference in vitamin D
level across BP status groups

Age

● Negative correlation
between vitamin D with SBP
only
● Higher SBP with vitamin D
deficiency

Retrospective
Aypak, 2014168 medical records of Turkish
Ankara- Turkey children, from outpatient
[39]
pediatric clinics
Obese: 26.2%; Overweight
20.2%; Lean: 53.6%
% Male: 51.8%
Age in years: Range: 4–16;
Median: 11

25(OH)D:
imunochemiluminescent assay
SBP and DBP: NR

None

No correlation between
vitamin D with SBP and DBP

Gul, 2017Tokat- Turkey
[49]

310 obese children (> 95th p
for sex-specific growth curves
and cut-off levels for Turkish
children), followed up at an
obesity clinic
Mean BMI(SD) in kg/m2: 29.22
(4.71)
% Male: 42.6%
Age in years: Range: 6–17;
Mean(SD): 12.10 (2.82)

Serum 25(OH)D:
chemiluminescence
immunoassay
Vitamin D status groups:
Deficient: < 37.5 nmol/L;
Insufficient: 37.5–72.5 nmol/L;
Sufficient: ≥ 75 nmol/L
SBP and DBP: NR
HTN: BP ≥ 95th p for age, sex
and height

None

● No differences in HTN
frequency, SBP and DBP
according to vitamin D status
groups
● No correlation between
vitamin D with SBP and DBP
● Lower vitamin D level
among hypertensive
participants

Kao, 2015Australia [16]

229 obese children and
adolescents (BMI ≥ 95th p for
age and sex-specific growth
curves) without pre-existing
disorders of vitamin D synthesis
or action, attending obesity
outpatient clinics
Mean BMI(SD) in kg/m2: 34.8
(94)
% Male: 50.7%
Age in years: Range: 2–18;
Mean(SD): 12.1 (3)

Serum 25(OH)D:
electrochemiluminescent
immunoassay or direct
chemiluminescence
competitive immunoassay
SBP and DBP: manual
sphygmomanometer in a
seated position with
appropriate cuff size

BMI; Age; Gender; Season

● Lower SBP and DBP with
increasing quintiles of
vitamin D
● Higher odds of elevated
BP with lower quintiles of
vitamin D
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Table 2 Characteristics and results of non-prospective cohort studies (Continued)
First author,
year- country

Study population

Outcomes evaluated and
evaluation method

Adjusted variables for
statistical analysis

Key findings

Kumaratne,
2017California, USA
[66]

234 healthy Hispanic
adolescents from pediatric
clinics not taking vitamin D
supplementation and having
no chronic illness by chart
review
BMI (< 85th p): 44.4%;
Overweight(≥ 95th p for age
and gender); Obese (BMI >
85th p for age and gender):
55.6%
% Male: 53%
Age in years: Range: 13–19;
Mean(SD): NR

Serum 25(OH)D: NR
Vitamin D status groups:
Deficient: < 50 nmol/L;
Adequate: ≥ 50 nmol/L
SBP and DBP: NR

None

No differences in SBP and
DBP across vitamin D status
groups, among all weight
categories

MacDonald,
2017- Alberta,
Canada [71]

217 overweight (BMI 85–97 p
for age and sex)and obese (>
97th p for age and sex)
children attending a pediatric
weight management clinic,
data collected from charts
Mean BMI(SD) in kg/m2:
Deficient group: 33.0 (8.1);
Sufficient group: 30.1 (6.6)
% Male: 50%
Age in years: Range: 12–18;
Mean(SD): 12.0 (2.9)

Serum 25(OH)D: according to
standard methodologies
Vitamin D status groups:
Deficient: < 50 nmol/L;
Sufficient: > 50 nmol/L
SBP and DBP: by an automatic
BP machine with appropriate
cuff size

None

No differences in SBP and
DBP across vitamin D status
groups

SmotkinTangorra,
2007- New
York, USA [95]

217 obese (>95th p for age
and sex) children and
adolescents, recruited from a
pediatric endocrine clinic at an
infants and children's hospital
Mean BMI(SD) in kg/m2: 32.2
(6.4)
% Male: 45.6%
Age in years: Range: 7–18;
Mean(SD): 12.9 (5.5)

25(OH)D: NR
Vitamin D status groups:
Insufficient: < 50 nmol/L
SBP: 1 measure in seated
position

None

Higher SBP with vitamin D
insufficiency

Serum 25(OH)D: NR
Vitamin D status groups:
Deficient: < 50 nmol/L;
Insufficient: < 75 nmol/L
SBP and DBP: NR
High BP: > 95th p for age and
sex

Age; Sex; Race; Location;
Season; Insulin level;
Hyperlipidemia; Total
comorbidities

Higher SBP with poorer
vitamin D status; no
difference in prevalence of
high BP and DBP

Serum 25(OH)D: HPLC
SBP and DBP: average of 3
readings in the sit-down position by electronic sphygmomanometer using an
appropriately sized BP cuff
placed on the right arm

BMI

Lower vitamin D level
among participants with
HTN; NS after adjustment

Williams, 2014- 150 obese children and
Pennsylvania,
teenagers (≥ 95 p) attending a
USA [103]
pediatric weight loss program
Mean BMI(SD) in kg/m2: NR
% Male: 35%
Age in years: Range: 5–19;
Mean(SD): Deficient group: 14.5
(3.1); Insufficient group: 13.6
(3.4)
Case-control
Liang, 2018China [70]

164 children from an
established cohort recruited
from elementary schools
divided into:
Hypertensive group: children
diagnosed with HTN, not under
treatment for vitamin
deficiency and not taking
antihypertensive drugs or other
medications, and free of other
diseases
Non-hypertensive group:
children without HTN or any
other disease that affect
vitamin absorption and
metabolism
Mean BMI(SD) in kg/m2:19.45
(4.59); hypertensive group:
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Table 2 Characteristics and results of non-prospective cohort studies (Continued)
First author,
year- country

Study population

Outcomes evaluated and
evaluation method

Adjusted variables for
statistical analysis

Key findings

22.51 (4.39); non-hypertensive
group: 16.36 (1.94)
% Male: 50.6%
Age in years: Range: 6–12;
Mean(SD): 9.81 (1.62)
Interventional (baseline assessment)
Al Daghri,
2016- Riyadh,
Saudi Arabia
[109]

77 children and adolescents,
overweight/obese, with fasting
blood glucose 5.6–6.9 nmol/L,
without acute or chronic
medical conditions, not taking
vitamin D supplements,
recruited from public schools
and health centers
Mean BMI(SD) in kg/m2: 32.31
(5)
% Male: 33.5%
Age in years: Range: 12–17;
Mean(SD): NR

Serum 25(OH)D: COBAS e-411
automated analyzer
SBP and DBP: average of 2
readings, at rest

None

Inverse correlation between
vitamin D with DBP only

Khayyatzadeh,
2018- Iran [63]

988 healthy adolescents not
taking medications or
supplements
Mean BMI(SD) in kg/m2: 21.07
(4.2)
% Male: 0%
Age in years: Mean(SD):
Deficient group: 14.5 (1.53);
Insufficient group: 14.7 (1.51);
Sufficient group: 15.2 (1.53)

Serum 25(OH)D:
electrochemiluminescence
Vitamin D status groups:
Deficient: < 50 nmol/L;
Insufficient :50–74.9 nmol/L;
and Sufficient: > 75 nmol/L
SBP and DBP: standard
procedure

None

No differences in SBP and
DBP across vitamin D status
groups

Ohlund, 2020Umea and
Malmo,
Sweden [82]

206 healthy children recruited
for a vitamin D
supplementation study
Mean BMI(SD) in kg/m2: NR
% Male: 46.1%
Age in years: Range: 5–7;
Mean(SD): NR

Serum 25(OH)D2 and
25(OH)D3: MS on an API 4000
LC/MS/MS system (AB Sciex)
SBP and DBP: using an
automated oscillometric
sphygmomanometer in Umea,
and an automatic BP monitor
in Malmo

Gender; Skin color; Study site;
Mothers’ education

Inverse association between
vitamin D with SBP and DBP,
in adjusted model

Smith, 2018United
Kingdom [94]

110 healthy adolescents, not
taking vitamin D supplement
or planning a winter sun
vacation
Obese (≥ 95th p for age): 7%;
Overweight (≥ 85– < 95th p
for age): 12%; Normal (≥ 2nd–
< 85th p for age): 81%
% Male: 43%
Age in years: Range: 14–18;
Mean(SD): 15.9 (1.4)

Serum 25(OH)D: liquid
Sex; Age; BMI z-score; Tanner
chromatography-tandem mass stage; Physical activity
spectrometry
SBP and DBP: average of 3
measurements, 1-min apart,
using an automatic BP monitor,
in upright position with the
arm supported

No association between
vitamin D with SBP and DBP

Cross-sectional baseline assessments from prospective cohort studies
Kwon, 2015South Korea
[67]

205 prepubertal children from
Ewha Birth and Growth Cohort
Study
Mean BMI(SD) in kg/m2: NR
% Male: 53.2%
Age in years: Range: 7–9;
Mean(SD):7.89 (0.85)

Serum 25(OH) D:
radioimmunoassay
SBP and DBP: average of 2
readings, 5 min apart, by an
automatic device with the
correct cuff size and the arm
properly supported

Age; Sex; BMI z-score; Birth
order; Fruit/fruit juice intake;
Maternal educational level

No association between
vitamin D with SBP and DBP,
in adjusted model

Williams, 2012Avon,
Southwest
England [101]

4274 children from the Avon
Longitudinal Study of Parents
and Children at 9 years of
follow-up
Mean BMI(SD) in kg/m2: 17.6
(2.7)
% Male: NR

25(OH)D: HPLC
Season-adjusted 25(OH)D3
Total 25(OH)D: sum of
25(OH)D2 and unadjusted
25(OH)D3
SBP and DBP: mean of 2
measurements, using a Vital

Age; Gender; Ethnicity;
Socioeconomic position; Waist
circumference; PTH; Circulating
calcium and phosphate level

No association between
vitamin D with SBP and DBP,
in adjusted model
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Table 2 Characteristics and results of non-prospective cohort studies (Continued)
First author,
year- country

Study population

Outcomes evaluated and
evaluation method

Age in years: Mean(SD): 9.86
(0.32)

Signs monitor, at rest, with the
arm supported at chest level

Adjusted variables for
statistical analysis

Key findings

Cross-sectional baseline assessment from a prospective cohort study and cross-sectional
Nandi-Munshi,
2017- USA [79]
NHANES
(2001–2006):
Cross-sectional
SNAS:
Prospective
cohort
(baseline
assessment)

NHANES: 8789 children and
adolescents
Obese: 19.79%; Overweight:
16.48%; Lean: 63.73%
% Male: 49.9%
Age in years: Range: 6–19
SNAS: 938 youth with type 1
diabetes
Obese: 13.02%; Overweight:
21.04%; Lean: 65.94%
% Male: 52.2%
Age in years: up to 19

NHANES:
None
Serum 25(OH)D:
radioimmunoassay
SBP and DBP: average of up to
3 measures, at rest, using a
mercury sphygmomanometer
BP: normal: SBP and DBP <90th
p; pre-HTN: SBP or DBP ≥
90th–< 95th p; HTN: SBP or
DBP ≥ 95th p
SNAS:
Serum 25(OH)D:
chemiluminescence
immunoassay based on a
linkage between specific
vitamin D antibody-coated
magnetic particles and an isoluminol derivative
SBP and DBP: average of 3
measures, using a mercury
sphygmomanometer
HTN: BP > 90 p for age, sex,
and height, or use of
antihypertensive drugs

No difference in vitamin D
level among normotensive
and those with HTN

BMI body mass index, SD standard deviation, 25(OH)D 25-hydroxyvitamin D, ELISA enzyme-linked immunosorbent assay, SBP systolic blood pressure, DBP diastolic
blood pressure, NR not reported, USA United States of America, p percentile, BP blood pressure, EPITeen EPIdemiological health Investigation of Teenagers in Port,
HELENA Healthy Lifestyle in Europe by Nutrition in Adolescence, HTN hypertension, NESA Nucleo de Estudos da Saude do Adolescente, HPLC high-performance
liquid chromatography, NHANES National Health and Nutrition Examination Survey, Q quartile, MAP mean arterial pressure, HDL high-density lipoprotein
cholesterol, KNHANES Korean National Health and Nutrition Examination Survey, KMOSES Korean Metabolic Disorders and Obesity Study in Elementary School
Children, OSCIR Oxidative Stress in Childhood Insulin Resistance, PTH parathyroid hormone, LC/MS liquid chromatography/mass spectrometry, SE standard error,
SEM standard error to the mean, IU international unit, IQR interquartile range, EPA eicosapentaenoic acid, DHA docosahexaenoic acid, NAFLD non-alcoholic fatty
liver disease, 1,25(OH)2D 1,25-dihydroxyvitamin D, CI confidence interval

[30, 32–34, 38–41, 43, 44, 49, 51, 52, 59, 63, 66, 69, 71,
72, 77, 78, 88, 93, 104, 108] did not report such findings.
Regarding the relationship between vitamin D and DBP,
twelve [28–32, 47, 73, 77, 98, 104, 108, 109] found a significant inverse association (of which two [31, 109] in boys
only), whereas most of the studies (n = 21) [33, 34, 38–41,
44, 49, 51, 52, 59, 63, 66, 69, 71, 72, 81, 88, 89, 92, 93] did
not. Regarding hypertension, three studies [47, 98, 104]
found higher prevalence with poorer vitamin D status. In
contrast, two studies [49, 96] did not report any relationship between vitamin D and hypertension status.
Regarding the four studies [46, 54, 68, 107] that adjusted for age and/or gender, all of them [46, 54, 68,
107] found a significant inverse association between vitamin D and SBP. Also, three [46, 54, 68] reported a negative relationship with DBP; yet, only one study [107] did
not find any association between vitamin D and DBP.
One study [46] reported on higher prevalence of hypertension with lower vitamin D levels. The only study [58]
that adjusted for BMI and physical activity found a
higher SBP with vitamin D deficiency, but did not find
any association between vitamin D and DBP, as well as
the prevalence of hypertension.

Out of the six studies [14, 35, 37, 61, 80, 84] which adjusted for age, gender, and/or anthropometric measurements including BMI, three [35, 61, 80] found a
significant inverse association between vitamin D and
SBP, whereas another three [14, 37, 84] did not find
such a relationship. Two studies [61, 80] reported a significant negative association between vitamin D and
DBP, whereas four [14, 35, 37, 84] did not. The only
study [14] that assessed high BP did not report any significant association with vitamin D.
Regarding the three studies [53, 62, 85] that adjusted
for age, gender, anthropometric measurements, and/or
sexual maturation level, one [85] found a significant inverse association with SBP, while two [53, 62] did not
find such an association. Further, one [85] found a significant inverse association with DBP, whereas two [53,
62] did not find any association. The only study [85] that
assessed high BP status, reported an inverse relationship
with vitamin D.
Regarding the 27 studies [15, 16, 36, 42, 45, 48, 50,
55–57, 64, 65, 67, 74, 75, 78, 82, 86, 87, 90, 91, 94, 97,
100, 101, 103, 105] which adjusted for multiple confounding factors, eleven studies [15, 16, 48, 55, 65, 82,
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Failure to adequately control confounding

Flawed measurement of outcome

First Author, Year

Flawed measurement of exposure

86, 91, 97, 100, 103] reported a significant inverse relationship between vitamin D and SBP, whereas twelve
[36, 42, 45, 50, 56, 57, 67, 75, 87, 90, 94, 101] found no
such relationship. Eight studies [16, 48, 55, 65, 82, 86,
87, 97] found a significant inverse relationship between
vitamin D and DBP, yet, the majority (n = 14) [15, 36,
42, 45, 50, 56, 67, 75, 90, 91, 94, 100, 101, 103] found no
such association. Finally, six [16, 65, 75, 78, 91, 105]
found an inverse association between vitamin D and elevated BP status, whereas three [64, 74, 103] did not.
Only eleven studies [14, 42, 43, 49, 70, 76, 79, 83, 91,
99, 106] investigated vitamin D levels across groups of
BP status. Among them, four studies [49, 70, 83, 91]
found a lower vitamin D level in participants with elevated BP compared with their counterparts; whereas
seven [14, 42, 43, 76, 79, 99, 106] did not find a difference in vitamin D level among normotensive participants and those with high BP.
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Failure to develop and apply appropriate eligibility criteria
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Cross-sectional
Al Daghri, 2010 [28]
Al Daghri, 2015 [29]
Al Daghri, 2015 [31]
Al Daghri, 2016 [30]

Assessment of risk of bias

The assessment of risk of bias of non-prospective cohort
studies is presented in Fig. 3. Developing and/or applying appropriate eligibility criteria were flawed in seven
studies [16, 39, 49, 66, 71, 95, 103] and were unclear in
another eight [43, 44, 51, 59, 73, 81, 97, 104]. Interestingly, seven studies [43, 52, 64, 66, 95, 103, 106] did not
describe the measurement of vitamin D, another 30 [14,
16, 29, 32, 37–39, 43, 49, 51, 53, 54, 57, 63, 66, 69, 71,
72, 80–82, 86, 88, 92, 98, 103, 106–109] did not provide
a detailed description of BP measurement, and 29 [28,
31, 33–36, 42, 44–46, 48, 50, 52, 55, 56, 58, 59, 61, 67,
68, 76–78, 85, 90, 95, 96, 101, 109] had a high risk of
bias for BP measurement. Only 29 studies [15, 16, 36,
42, 45, 48, 50, 55–57, 61, 62, 64, 65, 67, 74, 75, 82, 85–
87, 90, 91, 94, 97, 100, 101, 103, 105] provided results
adequately adjusted to potential confounders.

Discussion
Vitamin D deficiency is a global and pressing public
health problem even in countries that have an abundance of sunshine throughout the year [110], and in
countries where vitamin D supplementation has been
implemented for years [8, 111]. Despite the striking lack
of data pertaining to children and adolescents worldwide
[112], available evidence pinpoints a widespread vitamin
D deficiency specifically in this age group [113–118].
This deficiency can be attributed to atmospheric and environmental determinants such as high latitude and air
pollution; endogenous characteristics such as genetics,
skin pigmentation, obesity, and limited physical activity;
and behavioral factors, such as sun avoidance, reduced
outdoor activities, and use of sunscreen [119]. Similarly,
the prevalence of elevated BP in this age group has been
on the rise [2]. Interestingly, factors associated with

Al Daghri, 2018 [32]
Al Saleh, 2013 [35]
Alemzadeh, 2012 [33]
Alemzadeh, 2016 [34]
Ashraf, 2011 [37]
Ashraf, 2014 [36]
Atabek, 2014 [38]
Bacha, 2019 [40]
Banzato, 2014 [41]
Cabral, 2016 [42]
Cheraghi, 2012 [43]
Choi, 2014 [44]
DeMoraes, 2014 [45]
Depiero Belmont, 2015 [46]
Dura-Trave, 2020 [47]
Ganji, 2011 [15]
Ghobadi, 2019 [48]
Ha, 2013 [50]
Hannesdottir, 2017 [51]
Hassan, 2015 [52]

Fig. 3 Risk of bias of the non-prospective cohort studies
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Hirschler, 2012 [53]

Skrzypczyk, 2018 [93]

Hirschler, 2013 [54]

Teixeira, 2018 [96]

Hirschler, 2019 [55]

Tomaino, 2015 [97]

Hirschler, 2019 [56]
Izadi, 2020 [57]

Valle, 2019 [98]
Williams, 2011 [100]

Jang, 2013 [58]

Wojcik, 2017 [104]
Kardas, 2013 [59]

Xiao, 2020 [105]
Kelishadi, 2014 [61]

Yousefichaijan, 2019 [106]
Khadgawat, 2012 [62]

Zhou, 2011 [107]
Kim, 2018 [64]

Retrospective
Kumar, 2009 [65]

Aypak, 2014 [39]
Lee, 2013 [14]

Gul, 2017 [49]
Lee, 2015 [68]

Kao, 2015 [16]
Lee, 2016 [69]

Kumaratne, 2017 [66]
Malyavskaya, 2017 [108]

MacDonald, 2017 [71]
Matter, 2016 [72]

Smotkin-Tangorra, 2007 [95]
Mellati, 2015 [73]

Williams, 2014 [103]
Milagres, 2017 [74]

Case-control

Moore, 2017 [75]

Liang, 2018 [70]
Muhairi, 2013 [76]

Interventional (baseline assessment)
Nam, 2012 [77]

Al Daghri, 2016 [109]
Nam, 2014 [78]

Khayyatzadeh, 2018 [63]
Nsiah-Kumi, 2012 [80]

Ohlund, 2020 [82]
Nwosu, 2013 [81]

Smith, 2018 [94]
Oliveira, 2014 [83]

Longitudinal (baseline assessment)
Olson, 2012 [84]

Kwon, 2015 [67]
Pacifico, 2011 [85]

Williams, 2012 [101]
Parikh, 2012 [86]

Longitudinal (baseline assessment) and cross-sectional
Peterson, 2015 [87]

Nandi-Munshi, 2017 [79]

Pirgon, 2013 [88]
Prodam, 2016 [89]
Rafraf, 2014 [90]

Low risk of bias

Unclear risk of bias

High risk of bias

Fig. 3 Continued

Reis, 2009 [91]
Simpson, 2020 [92]

Fig. 3 Continued

decreased skin production of vitamin D, including high
latitude, industrialization, and dark skin, were also
shown to be associated with increased BP levels [120].
Thus, the association between vitamin D and BP gained
increasing attention over the last couple of years.
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Accumulating evidence ranging from molecular mechanisms to biochemical (physiological) and clinical data
suggests that vitamin D deficiency contributes to hypertension and proposes an antihypertensive effect of this
vitamin, through vasculo- and renoprotective effects,
suppression of the renin-angiotensin-aldosterone system,
and effects on calcium homeostasis, among others [120].
Yet, to date, epidemiological and experimental data has
not provided conclusive evidence about the association
between BP and 25(OH)D concentrations, and available
results are inconsistent with neither inverse nor an independent relationship reported [120, 121]. In order to
thoroughly investigate the association between vitamin
D and BP in children and adolescents, we conducted a
systematic review of observational studies. We provided
separate analyses for prospective cohort and nonprospective cohort studies (cross-sectional, retrospective,
and case-control). We opted this approach since in nonprospective cohort studies, the temporal relationship between exposure and outcome can often not be determined; thus, it is not possible to determine the direction
of causality of the reported relationship [122]. In contrast, although observational cohort studies hold a lower
position in the evidence rankings compared with randomized controlled trials (RCTs), their longitudinal findings may shed light on the direction of causality [122]
and would, therefore, facilitate causal inference [123].
Our search identified three prospective cohort studies
that explored the association between childhood 25(OH)D
status and BP during later childhood and adolescence.
The three studies showed no association between vitamin
D and BP. However, due to the limited number of studies
and limited sample size, the conclusions that can be
drawn from this analysis are considerably limited, and the
clinically relevant information provided is not novel.
The vast majority of the studies identified in our review were non-prospective cohort, which mainly did not
show a consistent inverse association between 25(OH)D
and SBP or DBP levels, or hypertensive status. Possible
reasons for the inconsistency in the findings of these
studies might relate to the different methodologies used
to evaluate vitamin D status and BP, as well as the
flawed evaluation of the latter in some studies, the wide
difference in the sample size, seasonality, and difference
in maturity (Tanner stage) of the participants, in
addition to other physiological and environmental factors [6, 11, 12, 25, 124, 125].
In specific, for the majority of these studies, BP evaluation was mainly based on the average of two readings.
This method yields a crude estimation of the average BP
level and may be subject to artifacts such as regression
to the mean. Recent data among children suggest that
the first three measurements differ significantly from the
average BP, while the fourth till tenth readings do not,
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and suggest that in children, the fourth BP reading
might be used as a reliable approximation, and BP measurement might be improved by including ten measurements [124]. Only two studies [41, 93] adopted
ambulatory blood pressure monitoring (ABPM), which
is a superior technique [125] and is considered the gold
standard of BP measurements in children and adolescents, as it precisely characterizes changes in BP
throughout daily activities, correlates more with target
organ damage [126, 127]. Benzato et al. [41] evaluated
the relationship between 24-h BP patterns and vitamin
D levels in 32 obese children and showed that low levels
of vitamin D were associated with a higher BP burden,
especially at night. In contrast, Skrzypczyk et al. [93]
evaluated 49 children with arterial hypertension and
found that vitamin D status did not correlate with office
BP nor ABPM parameters except for heart rate, suggesting negative influence of vitamin D on arterial wall,
which requires further investigations. Up-till-now,
ABPM and other reliable estimates of average BP, such
as repeated measurements, were rarely used in large epidemiological and clinical studies in children and even in
adults [120].
The lack of a significant association between vitamin
D status and BP might be attributable to the recruitment
of normotensive participants in the vast majority of the
studies [121]. Yet, even in studies investigating vitamin
D levels across groups of BP status, the results were inconsistent. And, while the majority these studies did not
find a difference in vitamin D level among normotensive
participants and those with high BP, four found a lower
vitamin D level in participants with elevated BP compared with their counterparts. Further investigating the
reason behind these mixed results through prospective
cohort studies is warranted, especially that Reis et al.
[91] who used data from a large sample from NHANES
2001-2004 demonstrated a lower mean vitamin D
among subject with high BP. These same inconsistent
findings were reported in the adult population [120].
Through a systematic review of the literature investigating the pediatric population, Abboud [24] showed no
effect of vitamin D supplementation on SBP or DBP in
RCTs, and only a significant small decrease in DBP in
non-randomized trials. The quality of evidence of this
analysis ranged between low and moderate. Yet, the author acknowledged the small number of included studies, and the fact that all participants were normotensive
at baseline, which might mitigate any effect of vitamin D
on reducing BP. Similarly, Hauger et al. [128], through a
systematic review of RCTs, found no effect of vitamin D
supplementation on cardiometabolic health in childhood
and adolescence, except for a beneficial impact of increasing 25(OH)D above 70 nmol/L on insulin resistance
only in obese subjects, which still needs to be confirmed
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in adequately powered, high-quality RCTs. The authors
acknowledged the low risk of bias in the included studies, but advised caution when interpreting their results
as they are based on a relatively limited number of available RCTs. These results are in line with the findings reported among adults showing that vitamin D
supplementation did not affect cardiometabolic outcomes, including BP [129–131]. Only, Witham et al.
[132], through a systematic review of the literature and a
meta-analysis, showed a small but significant fall in DBP
with vitamin D supplementation only among adults with
elevated BP, whereas no reduction in BP was observed
in people who were normotensive at baseline. Accordingly, while observational studies might show associations between low 25(OH)D concentrations and elevated
BP, interventional studies have not confirmed that optimizing vitamin D status through supplementation has
antihypertensive effects. It could be deduced that associations between 25(OH)D and BP are not causal. This
was also suggested by a large systematic review and
meta-analysis on the relationship between vitamin D status and a wide range of acute and chronic health disorders [133].
Finally, it is always worthy to note that when discussing the effects of vitamin D on BP, one must consider
the extremely rare yet relevant issue of toxicity with
mega doses of vitamin D and associated-hypercalcemia
[134], which might lead to reversible hypertension [135].
Data from Tomaino et al. [97] indicate a U-shaped relationship between SBP and 25(OH)D, and inverse Jshaped relationships between DBP and MAP with serum
25(OH)D status.

Strengths and limitations
To our knowledge, this is the first review to systematically assess the association between vitamin D status and
BP in children and adolescents, according to a predefined protocol, and following standard methods for
reporting systematic reviews [26]. We searched multiple
databases and did not set limits to publication language
or time, to increase the comprehensiveness of our
search. In addition, we critically appraised included studies. Yet, one limitation of our work relates to the quality
of the included records. We included observational studies, only three of them were prospective cohort. The
remaining included studies were non-prospective cohort
(cross-sectional, retrospective, case-control), among
which more than half did not adequately control for significant potential confounders. Although the majority of
the studies assessed serum concentration of 25(OH)D
which is considered the best determinant of vitamin D
status [136], few studies adopted rigorous methodology
for measuring BP, such as the use of random-zero
sphygmomanometers, multiple readings, or automated
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measurement [132], which may lead to a suboptimal assessment of BP. The quality of evidence of our review is
limited by the variable study quality, significant heterogeneity of outcome assessment methods, and study populations. All of which limit our ability to draw a solid
conclusion regarding the relationship between vitamin D
status and BP. Accordingly, our results suggest of a lack
of association, which are certainly not robust enough
and should be interpreted with caution.

Conclusions
Accumulating evidence, ranging from physiological
mechanisms, to epidemiological data suggests a link between vitamin D deficiency and elevated BP. Yet, conclusive evidence on the antihypertensive effects of vitamin
D remains lacking. The results on the relationship between vitamin D status and BP in children and adolescents varied between the studies, and mainly pointed
towards lack of association. In order to provide a clearcut answer on the antihypertensive effects of vitamin D,
future work should assess the effect of vitamin D on BP
reduction in hypertensive patients through powered,
high-quality and long-term RCTs, and should be
followed by larger-scale studies examining the impact of
vitamin D on hard outcomes, including cardiovascular
events and death. If the association proves to be causal,
optimizing vitamin D status through supplementation in
the pediatric population could slow the rising BP prevalence in this population group. In light of the widespread
vitamin D deficiency, and the various health benefits of
this vitamin on the musculoskeletal [137], immune
[138], neurological [139], and cardiovascular [140] systems, optimizing vitamin D status in the pediatric population remain needed.
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